Alabama's Shelby County Opens First Inpatient Addiction Treatment Center as State Confronts Massive Treatment Gap

Shelby County, Alabama, is preparing to open its first inpatient addiction and mental health treatment center—a milestone that highlights both progress and persistent gaps in a state where nearly one in five residents need substance use treatment but fewer than one in twenty actually receive it.

Longleaf Lodge, operated by Longleaf Recovery and Wellness, will offer 50 residential beds alongside 10 detox beds when it opens its doors in the coming weeks. The facility joins existing outpatient centers the organization runs in Baldwin County, Huntsville, and Birmingham, but represents the first time Shelby County residents will have access to residential addiction care without leaving their community.

For Colin Harris, founder and CEO of Longleaf Recovery and Wellness, the expansion addresses a problem he knows personally. "My family and I struggled to find treatment options for me many years ago here in Alabama, and the choices were very limited," Harris told reporters last week. "I eventually had to seek care out of state."

That experience—needing to travel hundreds of miles for treatment that should have been available locally—remains common across Alabama more than a decade later. According to the 2022-2023 National Survey on Drug Use and Health, approximately 19% of Alabamians aged 12 and older meet criteria for needing substance use treatment. Only about 5% actually receive it.

The Access Barrier Isn't Willingness—It's Availability

Kim Boswell, commissioner of the Alabama Department of Mental Health, explained that the treatment gap doesn't primarily reflect lack of motivation. Rather, infrastructure limitations create impossible delays precisely when individuals are most ready to change.

"When people are ready for treatment, they're often told they have to wait for a detox program," Boswell said during the facility announcement. "Sometimes that wait is a few weeks, or even up to 30 days, and in many cases, people decide not to pursue treatment at all."

Those delays carry deadly consequences in an era when fentanyl has made street drug supplies unpredictably lethal. The window between deciding to seek treatment and actually accessing care often becomes the difference between recovery and relapse—or between survival and overdose.

Medical detoxification serves as the essential first step for many individuals with severe alcohol or opioid dependence, where sudden cessation without medical supervision can trigger dangerous withdrawal symptoms including seizures, cardiac complications, and severe dehydration. But Alabama's shortage of detox beds means people in acute medical need frequently face wait lists measured in weeks rather than hours.

Harris emphasized the life-or-death urgency of immediate access: "A lot of people need to be stabilized and detoxed in a safe, professional setting to ensure they can recover properly." Without that supervised environment, individuals attempting to detox at home face serious health risks, while those who abandon treatment plans before admission often return to drug use at higher risk than before—having reduced their tolerance during brief abstinence attempts.

State officials believe the persistent shortage of residential treatment capacity has forced many Alabamians to either travel out of state for care or forgo treatment entirely. For families without the financial resources to pay for out-of-state residential programs—which can cost $10,000 to $30,000 per month—lack of local options effectively means no options at all.

Treating Two Crises Simultaneously

What distinguishes Longleaf Lodge from traditional single-focus facilities is its integrated approach to co-occurring mental health and substance use disorders. The center will provide psychiatric care alongside addiction treatment under the same roof, allowing clinicians to address depression, anxiety, trauma, and bipolar disorder concurrently with substance dependence.

"To have a facility that offers comprehensive care for both mental health and substance use is quite rare in Alabama," Boswell noted.

Research consistently demonstrates that co-occurring disorders are the norm rather than the exception among individuals seeking addiction treatment. Studies indicate that approximately 50% to 75% of people with substance use disorders also meet criteria for at least one mental health condition, and vice versa. Yet treatment systems historically evolved as separate silos, with addiction treatment occurring in specialized rehab centers and mental health care delivered through psychiatric facilities—forcing patients to navigate disconnected systems poorly designed to address their interconnected conditions.

Integrated care models have shown significantly better outcomes than sequential or parallel treatment approaches. When clinicians can adjust psychiatric medications while monitoring substance use patterns, recognize that apparent treatment resistance may reflect unaddressed addiction, and provide trauma-informed care acknowledging that both conditions often share common roots in adverse experiences, recovery rates improve substantially.

Alabama's fragmented behavioral health infrastructure has made this kind of coordinated care difficult to access outside major urban centers. Separate licensing systems, insurance billing complexities, and workforce shortages all contribute to the persistent separation between addiction and mental health treatment—even as clinical evidence and patient experiences make clear they cannot be meaningfully separated.

Settlement Funds Amid Uncertain Spending Plans

Longleaf Lodge's opening arrives as Alabama grapples with how to effectively deploy millions of dollars in opioid settlement funds now flowing into state and local coffers. The facility represents precisely the kind of treatment infrastructure expansion that settlement funds were intended to support—yet many Alabama municipalities have admitted they lack clear plans for their allocations.

A joint survey conducted by the Helios Alliance and the Alabama League of Municipalities revealed that many responding cities want more guidance on how to spend settlement dollars properly and effectively. Some officials, both in large and small communities, have told Attorney General Steve Marshall's office they simply do not know how to approach the spending decisions.

The uncertainty has led to questionable expenditures elsewhere in the country that raise concerns about Alabama's path forward. In Erie County, New York, the town of Lackawanna spent nearly all of its settlement money on fire department defibrillators—equipment critics argue has minimal impact on reversing the opioid crisis. Nationally, KFF Health News documented that $61 million in settlement funds were spent on law enforcement equipment during 2024 alone, including police gear and vehicles that have little direct connection to expanding treatment access or preventing overdose deaths.

Attorney General Marshall announced last week a partnership with the Helios Alliance to provide Alabama communities with a clearer, more strategic framework. The initiative brings to the state a data-driven approach already piloted in Mobile and Mobile County that uses statistical modeling to map overdose trends, identify service gaps, and craft targeted action plans.

"This is a generational opportunity, and it belongs to our local leaders," Marshall said in a statement. "No one understands this crisis better than the people living it, and no one has a more important role in solving it. The settlement funds are here, and the Helios approach gives our communities the tools to put them to work."

Greg Cochran, executive director of the Alabama League of Municipalities, confirmed that Marshall and the Helios Alliance will present their program during the organization's annual convention later this month in Montgomery, aiming to educate local officials on evidence-based uses of the funds.

Over the next two decades, state and local governments nationwide will receive more than $50 billion in opioid settlement funds from pharmaceutical companies, distributors, and pharmacy chains accused of contributing to the overdose epidemic. How effectively those dollars translate into expanded treatment capacity, harm reduction programs, and prevention initiatives will significantly shape overdose mortality rates for the next generation.

Private Expansion Where Public Infrastructure Falters

Longleaf Lodge operates as a private facility rather than a state-run institution, reflecting the broader American pattern of relying on private providers to fill gaps in public behavioral health infrastructure. While this model enables relatively rapid expansion—Harris can build and open facilities far faster than state bureaucracies typically move—it also raises questions about long-term sustainability and equity of access.

Private residential treatment centers typically require either commercial insurance coverage or substantial out-of-pocket payment from patients and families. While many accept Medicaid, reimbursement rates often fall below the actual cost of providing intensive residential care, which can limit the number of Medicaid beds facilities are willing to maintain.

Alabama Medicaid covers substance use disorder treatment including residential services, but chronic underfunding and administrative complexities have historically limited the network of participating providers. Whether Longleaf Lodge will accept Medicaid patients—and if so, how many of its 50 beds will be accessible to low-income Alabamians—remains unclear from public announcements thus far.

The alternative to private expansion would be significant public investment in state-operated treatment facilities, an approach that has fallen out of favor nationally as behavioral health services have increasingly shifted to community-based private providers. Yet that shift has often occurred without corresponding public funding following patients into private care, creating access barriers for those without commercial insurance or personal financial resources.

Harris's personal experience navigating Alabama's treatment gaps motivated him to build the infrastructure he once needed but couldn't find. That kind of entrepreneurial response to system failures has become common as individuals in recovery create the facilities, peer support networks, and advocacy organizations the public system has failed to adequately provide. Whether private innovation can fully substitute for adequate public investment remains an open question as states like Alabama confront treatment needs that far exceed current capacity.

The Wait That Kills

The three-to-four-week wait times Boswell described may sound manageable to those unfamiliar with addiction crises, but they represent an eternity when someone finally reaches the decision to seek help. Addiction specialists describe this moment of readiness as a fragile window that can close rapidly when met with bureaucratic delays or systemic barriers.

Individuals in acute crisis—experiencing withdrawal, facing legal consequences, abandoned by family members exhausted by years of broken promises, or confronting near-death overdoses—often reach treatment decisions from a place of desperation rather than calm reflection. That desperation provides powerful motivation but typically proves unsustainable across weeks of waiting. During that gap, the immediate crisis that prompted the treatment decision often recedes or resolves in other ways: the worst withdrawal symptoms pass, the court date gets postponed, the family member relents, the overdose scare fades from immediate memory.

Each day of delay allows space for ambivalence to return, for the brain's addiction circuitry to reassert its patterns, for triggers and cravings to overwhelm fragile resolve. Research on addiction treatment engagement consistently finds that reducing the time between initial contact and treatment entry significantly increases the likelihood that individuals will actually begin and remain in treatment.

Some progressive jurisdictions have adopted "treatment on demand" models that provide same-day access to medication-assisted treatment and rapid admission to residential programs when clinically appropriate. These approaches recognize that in addiction treatment, unlike elective procedures, delays directly correlate with mortality risk.

Alabama remains far from that standard. The opening of Longleaf Lodge's 60 combined beds represents meaningful progress but barely makes a dent in the gap between the estimated 19% of Alabamians needing treatment and the 5% currently receiving it. By rough calculation, that disparity represents hundreds of thousands of state residents who meet clinical criteria for substance use disorder treatment but have no access to care.

Building Toward an Adequate Response

No single facility launch, however well-designed, can solve Alabama's treatment access crisis. The state would need dozens of facilities like Longleaf Lodge, distributed across rural and urban communities, accepting patients regardless of insurance status, providing culturally competent care to diverse populations, and offering the full continuum from medical detox through residential treatment to intensive outpatient services and long-term recovery support.

Building that infrastructure requires sustained public investment at levels Alabama has not historically provided for behavioral health services. It requires training and recruiting enough addiction counselors, therapists, psychiatrists, and peer support specialists to staff expanded facilities—a workforce challenge that extends far beyond physical buildings. It requires Medicaid reimbursement rates sufficient to make serving low-income patients financially viable for providers rather than a money-losing proposition they minimize.

And it requires confronting the reality that leaving treatment access to market forces inevitably means underserved populations—those in rural counties, those without commercial insurance, those with complex co-occurring conditions requiring expensive specialized care—will continue falling through gaps that private facilities lack incentive to fill.

The partnership Attorney General Marshall announced between the state and the Helios Alliance represents recognition that simply distributing settlement funds without strategic planning risks wasting a once-in-a-generation opportunity. Whether that planning process will lead to the kind of comprehensive public investment needed, or merely optimize how settlement dollars supplement an inadequate baseline, remains to be determined by policy choices Alabama officials make in the months and years ahead.

For now, Shelby County residents facing addiction crises will soon have an option that didn't exist before—a local facility where they can access integrated care without leaving their community or waiting weeks for admission. That represents real progress, even as it highlights how far Alabama remains from ensuring that anyone ready for treatment can access it immediately, regardless of where they live or their ability to pay.

Colin Harris built what he once desperately needed but couldn't find. The question facing Alabama is whether the state will build a system where no one else has to make that same desperate search.